Prevalence of pre-diabetes and associated risk factors in an adult Omani population

International Journal of Diabetes in Developing Countries

Volumn 31, Issue 3, 2011, Pages 166-173

  Al Shafaee, Mohammed A ^a   Bhargava, Kamlesh ^a   Al Farsi, Yahya Mohammed ^a   McIlvenny, Shirley ^b   Al Mandhari, Ahmed ^a   Al Adawi, Samir ^a   Al Maniri, Abdullah ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b Natural Vibrant Health   (Australia)

Author keywords

Diabetes; Oman; Pre diabetes; Prevalence; Survey

Indexed keywords

EID: 84856287126     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.1007/s13410-011-0038-y     Document Type: Article

References (47)

1. Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab. 2003;29:6S9-18. (Pubitemid 37187086)
2. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med. 2006;12:62-6. (Pubitemid 43050076)
3. Shi HL, Fang JC, Zhu XX. Prevalence of diabetes mellitus and associated risk factors in an adult urban population in Shanghai. Diabetes Metabol. 1998;24:539-42. (Pubitemid 29048423)
4. Chi PW, Cheng TYD, Shan PT, Hui LH, Shu LW. Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care. 2005;28:2756-61. (Pubitemid 43958385)
5. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome -a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23:469-80.
6. Bertram MY, Vos T. Quantifying the duration of pre-diabetes. Aust New Zeal J Publ Health. 2010;34:311-4.
7. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007;334:299-302. (Pubitemid 46293963)
8. Henry P, Thomas F, Benetos A, Guize L. Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension. 2002;40:458-63.
9. Milman S, Crandall JP. Mechanisms of vascular complications in prediabetes. Med Clin North Am. 2011;95:309-25.
10. Rerkpattanapipat P, D'Agostino Jr RB, Link KM, Shahar E, Lima JA, Bluemke DA, et al. Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the multi-ethnic study of atherosclerosis. Diabetes. 2009;58:946-53.
11. Kilmer G, Hughes E, Zhang X, Elam-Evans L. Diabetes and prediabetes: screening and prevalence among adults with coronary heart disease. Am J Prev Med. 2011;40:159-65.
12. Colagiuri S. Epidemiology of prediabetes. Med Clin North Am. 2011;95:299-307.
13. Vendrame F, Gottlieb PA. Prediabetes: prediction and prevention trials. Endocrinol Metab Clin North Am. 2004;33:75-92. (Pubitemid 38438424)
14. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;7:393-403. (Pubitemid 34437694)
15. Ali HI, Baynouna LM, Bernsen RM. Barriers and facilitators of weight management: perspectives of Arab women at risk for type 2 diabetes. Health Soc Care Community. 2010;18:219-28.
16. Abo-Zenah H, El-Benayan A, El Nahas AM. Prevalence of increased albumin excretion rate in young Saudi adults. Nephron Clin Pract. 2008;108:155-62.
17. Khandekar R, Al Riyami A, Attiya M, Morsi M. Prevalence and determinants of blindness, low vision, deafness and major bone fractures among elderly Omani population of Nizwa Wilayat (Nizwa elderly population study-2005). Indian J Ophthalmol. 2010;58:313-20.
18. Khandekar RB, Tirumurthy S, Al-Harby S, Moorthy NSD, Amir I. Diabetic retinopathy and ocular co-morbidities among persons with diabetes at Sumail hospital of Oman. Diabetes Technol Ther. 2009;11:675-9.
19. Barakat MN, Youssef RM. Prevalence of dysglycemia and other cardiovascular risk factors among the rural population of Oman. Saudi Med J. 2008;29:1824-6.
20. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet. 2003;362:951-7. (Pubitemid 37159290)
21. Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P. Increasing prevalence of diabetes mellitus in Oman. Diabet Med. 2002;19:954-7. (Pubitemid 35356923)
22. Chedid R, Gannagé-Yared MH, Khalifé S, Halaby G, Zoghbi F. Impact of different metabolic syndrome classifications on the metabolic syndrome prevalence in a young Middle Eastern population. Metab Clin Exp. 2009;58:746-52.
23. Al-Lawati JA, Jousilahti P. Prevalence of metabolic syndrome in Oman using the International Diabetes Federation's criteria. Saudi Med J. 2006;27:1925-6. (Pubitemid 351850273)
24. Al-Shafaee MA, Ganguly SS, Bhargava K, Duttagupta KK. Prevalence of metabolic syndrome among prediabetic Omani adults: a preliminary study. Metab Syndr Relat Disord. 2008;6:275-9.
25. Al-Shereiqi S. Non communicable diseases screening: starts in Oman. Community Health Dis Surveill News (Oman). 2008;17:1-5.
26. Nichols GA, Arondekar B, Herman WH. Complications of dysglycemia and medical costs associated with non-diabetic hyperglycemia. Am J Manag Care. 2008;14:791-8.
27. Albarwani S, Al-Hashmi K, Al-Abri M, Jaju D, Hassan MO. Effects of overweight and leisure-time activities on aerobic fitness in urban and rural adolescents. Metab Syndr Relat Disord. 2009;7:369-74.
28. Al-Adawi S, Powell J. The influence of smoking on reward responsiveness and cognitive functions: a natural experiment. Addiction. 1997;92:1773-82. (Pubitemid 28006045)
29. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007;298:776-85. (Pubitemid 47263160)
30. Décary S, Dumont G, Lamarche B, Hogue JC, Tremblay AJ, Bergeron J, et al. Assessment of the validity of the frequently used lipid indices for predicting LDL peak particle diameter in a large cohort of 1955 normal and dyslipidemic subjects. Clin Biochem. 2010;43:401-6.
31. Al-Bahrani AI, Bakhiet CS, Bayoumi RA, Al-Yahyaee SA. A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia.Diabetes Res Clin Pract. 2005;69:44-51. (Pubitemid 40813411)
32. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middleincome countries. Lancet. 2007;370:1929-38. (Pubitemid 350192633)
33. World Health Organization. Preventing chronic diseases: a vital investment: WHO global report. Geneva: World Health Organization; 2005.
34. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53. (Pubitemid 38579764)
35. Soliman AT, Al-Salmi IS, Asfour MG. Epidemiology of childhood insulin-dependent diabetes mellitus in the Sultanate of Oman. Diabet Med. 1996;13:582-6. (Pubitemid 26201513)
36. Al-Lawati JA, Mabry R, Mohammed AJ. Addressing the threat of chronic diseases in Oman. Prev Chronic Dis. 2008;5:A99.
37. Barakat MN, Al-Shereiqi SZ. Operational and management Guidelines for the National non-communicable diseases screening program. Communicable Diseases Surveillance and Control. Directorate General of Health Affairs. Accessed in March 28: 2010 http://www.moh.gov.om/reports/Guidelines-Manual-for-the-national- NCD-screening-program.pdf.
38. Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Diabet Med. 2010;27:593-7.
39. Al-Daghri NM, Al-Attas OS, Al-Rubeaan K, Mohieldin M, Al-Katari M, Jones AF, et al. Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic Saudis. Cardiovasc Diabetol. 2007;6:18.
40. Bener A, Zirie M, Janahi IM, Al-Hamaq AO, Musallam M, Wareham NJ. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes Res Clin Pract. 2009;84:99-106.
41. Al Rashdan I, Al Nesef Y. Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: results from community-based national survey. Angiology. 2010;61:42-8.
42. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-55.
43. Saadi H, Nagelkerke N, Al-Kaabi J, Afandi B, Al-Maskari F, Kazam E. Screening strategy for type 2 diabetes in the United Arab Emirates. Asia Pac J Publ Health. 2010;22(3 Suppl):54S-9S.
44. Al-Isa A, Akanji AO, Thalib L. Prevalence of the metabolic syndrome among female Kuwaiti adolescents using two different criteria. Br J Nutr. 2010;103:77-81.
45. Al-Shoumer KA, Al-Asousi AA, Doi SA, Vasanthy BA. Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus. Ann Saudi Med. 2008;28:367-70.
46. Ganguly SS, Al-Lawati A, Al-Shafaee MA, Duttagupta KK. Epidemiological transition of some diseases in Oman: a situational analysis. World Hosp Health Serv. 2009;45:26-31.
47. Fonseca VA, Zinman B, Nauck MA, Goldfine AB, Plutzky J. Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies. Am J Med. 2010;123:S2-S10.